PALISADE BIO, INC. — Director's Dealing 2021

Sep 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2021-08-31

Reporting Person: Trenschel Robert J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-31	Common Stock	P	1750	$2.75	Acquired	1750	Direct
2021-09-07	Common Stock	P	2707	$2.78	Acquired	4457	Direct
2021-09-08	Common Stock	P	5000	$2.75	Acquired	9457	Direct
2021-09-09	Common Stock	P	3400	$2.89	Acquired	12857	Direct
2021-09-10	Common Stock	P	2142	$2.98	Acquired	14999	Direct